IDRx
Elizabeth Campbell is a seasoned professional in clinical trial management, currently serving as a Sr. Clinical Trial Manager at IDRx since October 2024. Prior experience includes significant roles at Fusion Pharmaceuticals, where Elizabeth held titles of Sr. Clinical Trial Manager, Clinical Trial Manager, and Sr. Clinical Trial Associate from February 2022 to October 2024. Elizabeth began the career at Constellation Pharmaceuticals as a Clinical Trial Associate and has also worked as a Clinical Research Coordinator at Dana-Farber Cancer Institute and a Research Assistant at Rhode Island College. Elizabeth holds a Master's degree in Medical Clinical Sciences from Boston University and a Bachelor of Science from the University of Vermont College of Agriculture and Life Sciences.
This person is not in any teams
This person is not in any offices
IDRx
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies.IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022.